Department


Pharmacy Practice

Vice Chair, Associate Professor
Focus: Infectious Disease

Contact Information
(518) 694-7225
joseph.carreno@acphs.edu


Speaker Request
Joseph Carreno, PHARM.D., M.P.H.

EDUCATION

  • M.P.H. Wayne State University, School of Medicine 
  • Infectious Diseases Pharmacy Fellowship, Henry Ford Hospital/Wayne State University
  • Post-graduate Year One Pharmacy Practice Residency, New York Methodist Hospital 
  • Pharm.D., Albany College of Pharmacy and Health Sciences

COURSES TAUGHT AT ACPHS

  • PTPM Infectious Diseases Module
  • Applied Methods in Epidemiologic Research
  • Inpatient Antimicrobial Management/Pharmacokinetics

ACADEMIC/RESEARCH INTERESTS

  • Dr. Carreno’s research interests focuses on the application of technology and epidemiologic methods to evaluate and develop antimicrobial stewardship programs. Specifically, Dr. Carreno is interested in pharmacists’ roles in active surveillance, anti-infective related adverse event prevention, and bacterial epidemiology of infectious diseases.

RESEARCH GRANTS

  • Carreno JJ (PI), Babowicz F. Lomaestro BM, Mitchell C, Tobin EH, George M. “Impact of a Novel Rapid Diagnostic Technique for Bacteremia in Patients Admitted to the ICU with Sepsis.” Albany College of Pharmacy and Health Sciences Scholarship of Discovery Award. Primary Investigator. 20% Effort. $5,000.
  • Carreno JJ (PI), Lomaestro BM, Racz M, Tobin EH, Falvo J, Evans A, Montero C. “Impact of a Multidisciplinary Team on Time to Sepsis Resolution.” ASHP Foundation Pharmacy Practice Initiative Demonstration Grant. Primary Investigator. 20% Effort. $75,000.
  • Carreno JJ (PI), Lomaestro B, Tietjan JC, Lodise TP. “Validation of a Bayesian Approach to Estimate Vancomycin Exposure in Obese Patients.” Society of Infectious Diseases Pharmacist Young Investigator Research Award. Primary Investigator. 10% Effort. Direct Costs $10,000. Funded.
  •  Carreno JJ, Chambers RM, Kilgore P, Weinmann A, Bloome M, Centi A, Rodriguez J, Davis SL (PI). “Antimicrobial Stewardship Provided Through Novel Approaches to Optimize Pharmacists’ Workflow (Stewardship-NOW)” ASHP/ASHP Foundation Pharmacy Practice Model Initiatives Demonstration Grant. Co-Investigator, 33% Effort. Total Direct Costs: $25,000.

HONORS AND ACHIEVEMENTS

  • Albany College of Pharmacy and Health Sciences Preceptor of the Year (2017)
  • Albany College of Pharmacy and Health Sciences Provost Technology Award (2014)
  • Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Infectious Diseases Fellow Grant (2013) 
  • Making a Difference in Infectious Diseases Pharmacotherapy (MAD-ID) Travel Grant (2013) 
  • IDWEEKTM Trainee Travel Grant (2012) 
  • Heroes of the Blizzard of 2010 commendation (2010)

PRACTICE SITE

Dr. Carreno is an Inpatient Clinical Pharmacist at Albany Stratton Veteran's Affairs Medical Center in Albany, NY.

PREVIOUS POSITIONS OR APPOINTMENTS

Clinical Pharmacy Instructor, Long Island University (2010 – 2011) 
Adjunct Clinical Pharmacy Instructor, Lebanese American University, Beirut, Lebanon (2010 – 2011)

SELECTED PUBLICATIONS

PUBLICATIONS

Lodise TP, Scheetz M, Carreno JJ, Chambers H, Fowler V, Holland TL. Associations Between Vancomycin Exposure and Acute Kidney Injury Within the Recommended Area Under the Curve Therapeutic Exposure Range Among Patients With Methicillin-Resistant  Bloodstream Infections. Open forum infectious diseases. 2022;9(2):ofab651.

Patel N, Bouchard J, Oliver MB, Badowski ME, Carreno JJ, Society of Infectious Diseases Pharmacists. Early clinical trial data and real-world assessment of COVID-19 vaccines: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2021;41(10):837–50.

Babowicz F*, LaPlante R*, Mitchell C, O’Donnell JN, Tobin E, George M, et al. Impact of Accelerate Pheno and BacT/Alert Virtuo on Clinical Processes and Outcomes in Patients with Sepsis and Concurrent Gram-Negative Bacteremia. Antimicrobial agents and chemotherapy. 2021;65(6).

Yu JY, McKenna VA, Dumyati GK, Lubowski TJ, Carreno J. Antibiotic Prescribing in New York State Medicare Part B Beneficiaries Diagnosed with Cystitis between 2016 and 2017. Open Forum Infect Dis. 2020;

Wagner JL, Carreno J, Kenney RM, Kilgore PE, Davis SL. Antimicrobial Stewardship Metrics that Matter. Infect Dis Clin Pract. 2019;

Carreno J, Tam IM, Meyers JL, Esterberg E, Candrilli S, Lodise T. Longitudinal, Nationwide, Cohort Study to Assess Incidence, Outcomes, and Costs Associated With Complicated Urinary Tract Infection. Open Forum Infect Dis. 2019;11(6). https://academic.oup.com/ofid/article/6/11/ofz446/5601270

Carreno JJ, Eaton R*, Itro L*, Babowicz F*, Falvo J, Tobin E, et al. Time to clinical response in sepsis associated with an algorithm for blood-culture pathogen identification using matrix-assisted laser desorption ionization time-of-flight mass spectroscopy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2019;76(7):460–9.

Rank EL, Lodise T, Avery L, Bankert E, Dobson E, Dumyati G, et al. Antimicrobial Susceptibility Trends Observed in Urinary Pathogens Obtained From New York State. Open forum infectious diseases. 2018;5(11):ofy297.

Carreno J, Smiraglia T*, Hunter C*, Tobin E, Lomaestro B. Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy. International journal of antimicrobial agents. 2018;52(5):643–50.

McLaughlin MM, Carreno JJ, Harpe SE, Jensen AO, Lomaestro B, Esterly JS. Multicenter evaluation of IV acyclovir use prior to, during, and after a national shortage. Infectious diseases (London, England). 2017;49(10):778–80.

Carreno JJ, Lomaestro B, Tietjan J, Lodise TP. Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling. Antimicrobial agents and chemotherapy. 2017;61(5).

Carreno JJ, Kenney RM, Divine G, Vazquez JA, Davis SL. Randomized Controlled Trial to Determine the Efficacy of Early Switch From Vancomycin to Vancomycin Alternatives as a Strategy to Prevent Nephrotoxicity in Patients With Multiple Risk Factors for Adverse Renal Outcomes (STOP-NT). The Annals of pharmacotherapy. 2017;51(3):185–93.

Carreno JJ, Lomaestro BM, Jacobs AL, Meyer RE, Evans A, Montero CI. Assessment of Time to Clinical Response in Patients with Sepsis Treated Before and After Implementation of a Matrix-Assisted Laser Desorption Ionization Time-of-Flight Blood Culture Identification Algorithm. Infection control and hospital epidemiology. 2016;37(8):916–23.

Carreno JJ, Kenney RM, Bloome M, McDonnell J, Rodriguez J, Weinmann A, et al. Evaluation of pharmacy generalists performing antimicrobial stewardship services. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2015;72(15):1298–303.

Werth BJ, Carreno JJ, Reveles KR. Shifting trends in the incidence of Pseudomonas aeruginosa septicemia in hospitalized adults in the United States from 1996-2010. American journal of infection control. 2015;43(5):465–8.

Carreno JJ, Lodise TP. Ceftaroline Fosamil for the Treatment of Community-Acquired Pneumonia: from FOCUS to CAPTURE. Infectious diseases and therapy. 2014;3(2):123–32.

Carreno JJ, Kenney RM, Lomaestro B. Vancomycin-associated renal dysfunction: where are we now? Pharmacotherapy. 2014;34(12):1259–68.

Dumkow LE, Kenney RM, MacDonald NC, Carreno JJ, Malhotra MK, Davis SL. Impact of a Multidisciplinary Culture Follow-up Program of Antimicrobial Therapy in the Emergency Department. Infectious diseases and therapy. 2014;3(1):45–53.

Carreno JJ, Jaworski A, Kenney RM, Davis SL. Comparative Incidence of Nephrotoxicity by Age Group among Adult Patients Receiving Vancomycin. Infectious diseases and therapy. 2013;2(2):201–8.

*Indicates ACPHS student author

CONFERENCES AND PRESENTATIONS

  1. Grillo M*, Barlow J*, Carreno JJ. Association between Outpatient Antibiotic Prescribing, Antimicrobial Resistance, and Initial Presentation to Inpatient Setting for Urinary Tract Infections Among Older Adults in New York State. IDWEEK 2021. September 2021.
  2. Babowicz F*, LaPlante R*, Mitchell C, George M, Carreno JJ. Impact of Accelerate Pheno System and Multidisciplinary Antimicrobial Stewardship Team on Early Utilization of Antibiotics in Gram-Negative Bacteremia. Abstract # SP-370. Virtual Poster Presentation. Virtual Meeting (due to COVID-19). December 2020.
  3. LaPlante R*, Babowicz F*, Mitchell C, George M, Carreno JJ, Impact of Accelerate Pheno System and a Multidisciplinary Antimicrobial Stewardship Program on Gram-Negative Sepsis Outcomes. Abstract # SP-382. Virtual Poster Presentation. Virtual Meeting (due to COVID-19). December 2020.
  4. Yu J, McKenna V, Dumyati G, Lubowski T, Carreno JJ. Statewide, Retrospective, Cohort Study of Medicare Part B Quinolone Prescribing for Cystitis in 2016 – 2017.IDWEEK 2019. Poster Presentation, Washington, DC. October 2019.
  5. Babowicz F*, LaPlante R*, Tobin E, Mitchell C, Carreno JJ. Can PK/PD data help inform our stewardship decision to restrict or prospectively audit vancomycin (VAN) and piperacillin-tazobactam (PTZ) co-prescribing? Making a Difference in Infectious Diseases Pharmacotherapy. Poster Presentation, Orlando Florida. May 2019.
  6. Carreno JJ, Lodise T. Assessment of cloud-based Bayesian software to estimate vancomycin exposure in obese individuals with limited pharmacokinetic sampling. European Congress of Clinical Microbiology and Infectious Diseases. Abstract # 3964. Poster Presentation, Amsterdam, Netherlands. April 2019.
  7. Eaton R*, Toti K* , Vitale G*, George M, Carreno JJ. Assessment of Time to Clinical Response in Patients with Sepsis Treated Before and After Implementation of a Twice-Daily Blood Culture Follow-up Program. Abstract # 8-220. American Society of Health-System Pharmacists Midyear Clinical Meeting 2018. Anaheim, CA. December 2018.
  8. Vitale G*, Eaton R*, Laquidara A*, Mitchell C, Carreno JJ. Inpatient antimicrobial stewardship medication use evaluation of meropenem at Albany Medical Center Hospital. Abstract # 8-239. American Society of Health-System Pharmacists Midyear Clinical Meeting 2018. Anaheim, CA. December 2018.
  9. Colgan KE*, Ciccone MG*, Sutton E, Carreno JJ. Quarterly Variation in Respiratory Fluoroquinolone and Macrolide Prescribing among Outpatient Medicaid Enrollees in Vermont, 2004 – 2017. Abstract # 8-235. American Society of Health- System Pharmacists Midyear Clinical Meeting 2018. Anaheim, CA. December 2018.
  10. Rank E, Lodise TP, Avery L, Bankert E, Dobson E, Dumyati G, Hassett S, Keller M, Lubowski T, Pearsall M, Carreno JJ. New York State Outpatient Regional Antibiogram for Urinary Pathogens : Have We Reached a Post Antibiotic Era for the Treatment of UTIs? Abstract. Poster presentation at IDWEEK 2018. San Francisco, CA. October 2018.
  11. Sangiovanni RJ*, Yager J*, Carreno JJ, O’Donnell JN, Lowry C, Carlyn C, Patel N. Retreatment with Vancomycin and Subsequent Risk of Acute Kidney Injury (AKI) among Veterans’ Affairs Patients who have Previously Experienced Vancomycin-associated AKI. Abstract 180. Poster presentation at American Society of Microbiology Microbe Meeting. New Orleans, LA. June 2017. Presenter: Patel.
  12. Carreno JJ, Smiraglia T*, Hunter C*, Tobin E, Lomaestro B. A Matched Cohort Study Evaluating the Comparative Incidence of Adverse Renal Outcomes in Patients Receiving Vancomycin and Piperacillin-Tazobactam in Combination or as Monotherapy. IDWEEK 2016. New Orleans, Louisiana. Abstract – 1011.
  13. Carreno JJ, Lomaestro B, Tietjan J, Lodise T. Validation of A Bayesian Approach to Estimate Vancomycin Exposure in Obese Patients. American Society of Microbiology Microbe 2016. Boston, Massachusetts. Abstract # 496.
  14. Carreno JJ, Bilan NM*, Itro LM*, Jacobs AL*, Smiraglia TA*, Evans A, Lomaestro B, Montero C. Association Between Time to Sepsis Resolution and Inpatient Mortality. 55th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California. Abstract #-K-318.
  15. Carreno JJ, Sutton E, Schulze K, DiCenzo R. Quarterly Variation in Respiratory Fluoroquinolone and Macrolide Prescribing among Outpatient Medicaid Enrollees in Vermont, 2004 - 2014. 55th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California. Abstract S-908.
  16. Wagner JL, Carreno JJ, Kenney RM, Kilgore PE, Davis SL. Antimicrobial Stewardship Metrics: Are We Chasing the Right Targets? 55th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California. Abstract S-(TBD). (selected for platform presentation)
  17. McLaughlin M, Carreno JJ, Harpe SE, Lomaestro B, Esterly J. Multicenter Evaluation of IV Acyclovir Use Prior to, During and After a National IV Acyclovir Shortage. 55th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, California. Abstract S-910.
  18. Carreno JJ, Lomaestro B, Tietjan J, Lodise TP. Prospective Validation of a Bayesian Approach to Estimate Vancomycin Exposure in Obese Patients. Albany College of Pharmacy and Health Sciences Annual Research Forum 2015. Albany, New York.
  19. Meyer R*, Evans A, Montero C, Lomaestro B, Carreno JJ. Nonequivalent dependent variable controlled, quasi-experimental evaluation of the impact of a rapid identification algorithm on time to sepsis resolution in patients with bloodstream infections. American Society of Health-Systems Pharmacists 2014 Midyear Meeting. Anaheim, California. Abstract # 5-399.
  20. Carreno JJ, Bradley S*, Garfinkel M*, Gervasio J*, Lyndaker K*, Bergeron C. Statistical Characterization of Antimicrobial Activity: Do Common Descriptions Hold Up To Unsupervised Data Analytics? 2014 IDWEEK. Pennsylvania Convention Center. Philadelphia, Pennsylvania. Abstract 216.
  21. Werth BJ, Carreno JJ, Reveles KR. Shifting Trends in the Incidence of Pseudomonas aeruginosa Septicemia in Hospitalized Adults from 1996 to 2010. 54th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, District of Columbia. Abstract K-1046.
  22. Carreno JJ, Lyndaker K*, Garfinkel M*, Gervasio J*, Evans A, Lomaestro B, Montero C. Impact of Matrix Assisted Laser Desorption Ionization Time of Flight Blood Stream Pathogen Identification on Time to Sepsis Resolution. 54th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, District of Columbia. K-659 (Selected for slide session).
  23. Malonzo P*, Lyndaker K*, Gervasio J*, Garfinkel M*, Bradley S*, Carreno JJ. Sepsis in Silico: a Simulated Approach to Discriminating SIRS, Sepsis, Severe Sepsis and Septic Shock. 17th Annual Making a Difference in Infectious Diseases Pharmacotherapy Meeting. Orlando, Florida. Abstract 35 – OR.
  24. Carreno JJ, Chambers RM, Davis SL, Vazquez JA. A Randomized Clinical Trial (RCT) Evaluating a Strategy to Prevent Nephrotoxicity in Patients Prescribed Vancomycin (STOP-NT). 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, Colorado. Abstract K – 711 (Selected for inclusion in Poster Walk).
  25. Carreno JJ, Jaworski A, Chambers RM, Davis SL. Vancomycin Nephrotoxicity: Age Ain’t Nothing But a Number. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, Colorado. K – 712.
  26. Carreno JJ, Martirosov DM, Krupinski J, Kurtser A, Chambers RM, Davis SL. Validation of a Clinical Prediction Rule To Identify Patients at Highest Risk of Acute Kidney Injury while Receiving Vancomycin. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, Colorado. Abstract K – 713.
  27. Wagner JL, Saad S, Cole KA, Lasak-Myall T, Davis SL, Carreno JJ. Challenges with Antibiotic Dosing in Patients Receiving Continuous Renal Replacement Therapy in Intensive Care Units. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, Colorado. Abstract K – 722.
  28. Carreno JJ, Bloome M, Rodriguez J, McDonnell JE, Weinmann A, Kilgore PE, Davis SL. Chambers RM. Antimicrobial Stewardship Provided Through a Novel Approach to Optimize Pharmacists’ Workflow (Stewardship-NOW!). 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, Colorado. K – 1289.
  29. Carreno JJ, Martirosov DM, Krupinski J, Kurser A, Chambers RM, Davis SL. Validation of a Prediction Rule To Identify Patients at Highest Risk of Acute Kidney Injury While Receiving Vancomycin. 16th Annual Making a Difference in Infectious Diseases Pharmacotherapy Meeting. Orlando, Florida. Abstract 11 – OR FRS.
  30. Jaworski A, Carreno JJ, Chambers RM, Davis SL. Vancomycin Nephrotoxicity: Age Ain’t Nothing But a Number. 16th Annual Making a Difference in Infectious Diseases Pharmacotherapy Meeting. Orlando, Florida. Abstract 12 – OR FRS.
  31. Saad S, Wagner J, Cole K, Lasak-Myall T, Carreno JJThe Effectiveness of a Dosing Policy Guideline for Continuous Renal Replacement (CRRT) Patients Across Intensive Care Units at Henry Ford Hospital. 16th Annual Making a Difference in Infectious Diseases Pharmacotherapy Meeting. Abstract 38 – E FRS. Orlando, Florida.
  32. Carreno JJ, Davis SL, Chambers RM, Vazquez JA. A Randomized Controlled Trial Evaluating a Strategy to Prevent Nephrotoxicity in High Risk Patients (STOP- NT). 9th Annual Eugene Applebaum College of Pharmacy Research Day. Detroit, Michigan.
  33. Dumkow LE, Carreno JJ, Chambers RM, MacDonald N, Davis SL, Malhotra M. Implementation of a Systematic, Multidisciplinary Follow-Up for Emergency Department Blood and Urine Cultures Improves Quality of Care and Cost. Henry Ford Hospital Quality Expo. Detroit, Michigan.
  34. Carreno JJ, Davis SL, Chambers RM, Vazquez JA. A Randomized Controlled Trial Evaluating a Strategy to Prevent Nephrotoxicity in High Risk Patients (STOP- NT). 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California. Abstract K - 1629
  35. Dumkow LE, Chambers R, MacDonald N, Carreno JJ, Maholtra MK, Davis SL. Implementation of a Collaborative Antimicrobial Culture Follow-up Program in the Emergency Department (ED) 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California. Abstract K - 240
  36. Carreno JJ, Davis SL, Chambers RM, Vazquez JA. A Randomized Controlled Trial Evaluating a Strategy to Prevent Nephrotoxicity in High Risk Patients (STOP- NT). 2012 Star of the North Fellowship Forum. Maddens on Gull Lake, Brainerd, Minnesota.
  37. Carreno JJ, Davis SL, Chambers RM, Tibbets R. Pharmacokinetically Optimized Combination Antibiogram for Carbapenem Non-Susceptible Gram-Negative Bacilli. 2012 ID Week. San Diego Convention Center. San Diego, California.
  38. Dumkow LE, Chambers R, MacDonald N, Carreno JJ, Maholtra MK, Davis SL. Culture Shock: Implementation of a Pharmacist-Managed Culture Follow-Up Program. 27th Annual Great Lakes Pharmacy Residency Conference. Purdue University, West Lafayette, Indiana.
  39. Carreno J, Wu G, Abraham T, Saad N, Vastey F, Balmir E. “Outcomes Associated with Inappropriate Vancomycin Therapeutic Drug Monitoring.” New York City Regional Residency Conference. Long Island University. Brooklyn, New York.
  40. Carreno J, Wu G, Abraham T, Saad N, Vastey F, Balmir E. “Outcomes Associated with Inappropriate Vancomycin Therapeutic Drug Monitoring.” New York Methodist Hospital Research Week. New York Methodist Hospital. Brooklyn, New York.
  41. Carreno J, Wu G, Abraham T, Saad N, Vastey F, Balmir E. “Outcomes Associated with Inappropriate Vancomycin Therapeutic Drug Monitoring.” 30th Eastern States Conference. Hershey Lodge. Hershey, Pennsylvania.
  42. Carreno J, Rapp J, Abraham T, Saad N, Vastey F, Balmir E. “Efficacy of medication delivery and administration in the emergency room: a hypothesis generating study” Submission ID: 232864. 45th ASHP Midyear Clinical Meeting and Exhibition. Anaheim Convention Center, Anaheim, California.
  43. Hass M, Carreno J, Hammad A. Synthesis and Antioxidant Activity of Mutual Prodrugs Derived from Tocopherol and Lipoic Acid. American Association of Pharmaceutical Sciences Annual Meeting, New Orleans, Louisiana, 2010.

*Indicates ACPHS student author